Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE1

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

NCT06411418

Intracranial Aneurysms

ACTIVE_NOT_RECRUITING NA

Pipeline Flex With SHield Technology Embolization - An International MulticEnter ObservationaL Post Market StuDy

NCT02719522

Intracranial Aneurysm

COMPLETED

Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms

NCT03815149

Intracranial Aneurysm Cerebral Aneurysm Subarachnoid Hemorrhage +4 more

UNKNOWN

Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)

NCT03873714

Intracranial Aneurysm

TERMINATED NA

Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device

NCT02186561

Intracranial Aneurysm

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments. The Pipeline™ Flex Embolization Device with Shield Technology™ is also indicated for use in the internal carotid artery up to the terminus for the endovascular treatment of adults (22 years of age or older) with small and medium wide-necked (neck width ≥ 4 mm or dome-to-neck ratio \< 2) saccular or fusiform intracranial aneurysm (IAs) arising from a parent vessel with a diameter ≥ 2.0 mm and ≤ 5.0 mm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SHIELD Study Arm

Active treatment with the Pipeline SHIELD Device

Group Type OTHER

SHIELD

Intervention Type DEVICE

Pipeline SHIELD device under study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SHIELD

Pipeline SHIELD device under study

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.